PARATEK PHARMACEUTICALS INC's ticker is PRTK and the CUSIP is 699374302. A total of 73 filers reported holding PARATEK PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $659,243 | -5.0% | 298,300 | +9.1% | 0.00% | 0.0% |
| Q1 2023 | $694,182 | +3.4% | 273,300 | -23.9% | 0.00% | 0.0% |
| Q4 2022 | $671,330 | -40.9% | 359,000 | -18.7% | 0.00% | -33.3% |
| Q3 2022 | $1,135,000 | +270.9% | 441,500 | +178.0% | 0.00% | +200.0% |
| Q2 2022 | $306,000 | -52.1% | 158,800 | -26.2% | 0.00% | -50.0% |
| Q1 2022 | $639,000 | -54.9% | 215,100 | -31.9% | 0.00% | -50.0% |
| Q4 2021 | $1,417,000 | -18.0% | 315,700 | -11.2% | 0.00% | 0.0% |
| Q3 2021 | $1,727,000 | -51.5% | 355,400 | -31.9% | 0.00% | -55.6% |
| Q2 2021 | $3,560,000 | -3.2% | 522,000 | +0.2% | 0.01% | -10.0% |
| Q1 2021 | $3,676,000 | +59.1% | 520,700 | +41.1% | 0.01% | +66.7% |
| Q4 2020 | $2,310,000 | +652.4% | 369,000 | +549.6% | 0.01% | +500.0% |
| Q3 2020 | $307,000 | +184.3% | 56,800 | +175.7% | 0.00% | – |
| Q2 2020 | $108,000 | – | 20,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Omega Fund Management, LLC | 2,138,872 | $55,119,000 | 27.83% |
| Abingworth LLP | 1,301,413 | $33,524,000 | 15.22% |
| Roumell Asset Management, LLC | 207,703 | $5,353,000 | 9.43% |
| GREAT POINT PARTNERS LLC | 415,338 | $10,703,000 | 4.17% |
| Aisling Capital LLC | 682,680 | $17,593,000 | 2.62% |
| Broadfin Capital, LLC | 530,283 | $13,665,000 | 0.73% |
| Baupost Group | 1,544,498 | $39,802,000 | 0.66% |
| Tekla Capital Management LLC | 691,000 | $17,807,000 | 0.64% |
| GENERAL AMERICAN INVESTORS CO INC | 277,076 | $7,140,000 | 0.59% |
| Lombard Odier Asset Management (USA) Corp | 140,000 | $3,607,000 | 0.26% |